Achieving RA Treatment Goals: Real-World Experience and Emerging Insights into DMARD Monotherapy

Achieving RA Treatment Goals: Real-World Experience and Emerging Insights into DMARD Monotherapy

On-Demand Webcast

Stanley Cohen, MD
Medical Director
Metroplex Clinical Research Center
Clinical Professor of Internal Medicine
University of Texas Southwestern School of Medicine
University of Texas Southwestern Medical School/Rheumatology Associates
Director, Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

Intended Learners

This activity is designed for rheumatology professionals, including rheumatologists and rheumatology residents and fellows, along with the multidisciplinary team of NPs, PAs, and nurses.

Learning Objectives

After completing this activity, participants should be able to:

  • Discuss the impact of recent guidance on the role of monotherapy, sequencing, treat-to-target goals, and new therapies in RA management
  • Explore recent real-world data and emerging insights into biologic and non-biologic DMARD monotherapy and the impact on treatment decisions
  • Evaluate recent and emerging agents, including JAK inhibitors, and their role in the management of RA
  • Develop personalized care plans utilizing evidence-based guidance, emerging data, treat-to-target, and shared decision-making strategies 
Activity Overview

This on-demand webcast is available with synchronized slides and video.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Release date: March 29, 2018
Expiration date: March 29, 2019
Estimated time to complete: 1 hour

There is no fee associated with this activity.

Participants who completed the live version of this activity are not eligible to receive credit for this enduring material.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards 1 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

Independent Clinical Reviewer: Marc D. Cohen, MD, Emeritus Professor of Medicine, Mayo Clinic, Clinical Professor of Medicine, University of Colorado Medical Center, Denver, Colorado

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee comprises Marc D. Cohen, MD, MPH, Stanley Cohen, MD, Susie Seaman, NP; Donna Brophy, Mary Johnson, Mike Kearney, Susan Kuhn, Randy Robbin, Margaret Stefan, and Susan Yarbrough, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Ms. Seaman: Advisory Board—Mölnlycke

Dr. Cohen and Dr. Cohen have disclosed no relevant financial relationships with any commercial interests.

Ms. Brophy, Ms. Johnson, Mr. Kearney, Ms. Kuhn, Mr. Robbin, Ms. Stefan and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that off-label/unapproved uses of drugs and/or devices will be discussed. Off-label/unapproved uses of drugs and/or devices will be disclosed during the webcast.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by independent educational grants from Lilly and Pfizer IGLC.